I called Genetech to try to get information today. The person I talked to told me they have not canceled the extended access program for T DM1 yet. They still have 9 sites open and are still planning to set up more. He also told me the phase 3 Emila study is still in operation. Other her2 studies involving Herceptin and/orTDM 1 such as the TDM4450g, MARIANNE, and the CLEOPATRA are still active.
I asked for more information and was directed to someone else. That person directed me to the Genetech website (
www.gene.com) and suggested I look in the media section regularly for updates. I followed her directions.
The latest press release can be found at
http://www.gene.com/gene/news/press-...etail&id=12947
I think it is a good idea to check for press releases regularly.
http://www.gene.com/gene/news/index....btn=Web+Search